therapeutics all along?
I note that you mention this was always the plan. I do recall that therapeutic options were listed as a "possibility" in the past, but was it clearly stated as the ultimate plan? (not saying you are wrong; I just thought that diagnosis was always the main thrust)
While treatment is huge, I still say that even diagnosis, if they can ever get a serious contract, would be enormous itself. For followup or high risk monitoring alone, I think you are talking billions.
It will be interesting to see how this release shakes things up. Quite unexpected for me (positive), as I was only hanging on because Dr Gold is still listed on board. Other company reps had lost credibility with me due to weak, inconsistent communication.
I hope this press release changes all of that. I hope it will yield some third party press ... otherwise it is back to "what is the game plan?!"
